Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 6/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 4/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1539567 | 1.00 | MAPT (0.59) | MAPTPOLBKDM4EGLARAB9A | |
| Hydrochloric Acid SCHEMBL29092125 | 0.98 | MAPT (0.58) | MAPTPOLBKDM4EGLARAB9A | |
| SCHEMBL28330058 | 0.86 | MAPT (0.52) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL8709730 | 0.84 | GSTA1 (0.61) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL29994104 | 0.84 | GSTA1 (0.61) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL14329003 | 0.83 | MAPT (0.46) | MAPTPOLBKDM4EGLARAB9A | |
| SCHEMBL15333218 | 0.83 | HSD17B14 (0.55) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL28337480 | 0.83 | MAPT (0.52) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL24383735 | 0.83 | KMT2A (0.50) | MAPTPOLBKDM4ERAB9ANPC1 | |
| SCHEMBL367924 | 0.82 | KMT2A (0.56) | MAPTKDM4ERAB9ANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695257-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF | Harman Finochem Limited (IN) | 2026-02-18 | — | — | EP | claimed |
| CN-119798149-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 宜昌天睿生物医药有限责任公司 | 2025-04-11 | — | — | CN | claimed |
| CN-115974835-B | Synthesis method of key intermediate of timonazolam | 湖南复瑞生物医药技术有限责任公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119143662-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 广西鲲宇药业有限公司 | 2024-12-17 | — | — | CN | claimed |
| WO-2024214109-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF | HARMAN FINOCHEM LIMITED (IN) | 2024-10-17 | — | — | WO | claimed |
| CN-116283968-B | Acetamido imidazopyridine compound and preparation method and application thereof | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2024-08-16 | — | — | CN | claimed |
| CN-115322144-B | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-115626913-B | Method for preparing key intermediate of Rayleigh Malun | 上海再启生物技术有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-116751157-A | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-116283968-A | Acetamido imidazopyridine compound and preparation method and application thereof | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2023-06-23 | — | — | CN | claimed |
| CN-116041254-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine serving as intermediate of rimazolam | 天津玖合成城企业管理合伙企业(有限合伙) | 2023-05-02 | — | — | CN | claimed |
| CN-114644612-B | Preparation method of benzodiazepine nerve inhibitor intermediate compound | 成都苑东生物制药股份有限公司 | 2023-04-28 | — | — | CN | claimed |
| CN-115974835-A | Synthesis method of key intermediate of remimazolam | 湖南复瑞生物医药技术有限责任公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115626913-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2023-01-20 | — | — | CN | claimed |
| CN-115322144-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-113717176-B | Method for preparing remazolam | 上海再启生物技术有限公司 | 2022-07-05 | — | — | CN | claimed |
| CN-114644612-A | Preparation method of benzodiazepine neuroleptic intermediate compound | 成都苑东生物制药股份有限公司 | 2022-06-21 | — | — | CN | claimed |
| CN-110746345-B | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 苏州永健生物医药有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114014839-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2022-02-08 | — | — | CN | claimed |
| EP-4695257-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF | Harman Finochem Limited (IN) | 2026-02-18 | — | — | EP | disclosed |
| CN-121248481-A | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 渭南师范学院 | 2026-01-02 | — | — | CN | disclosed |
| CN-121248481-A | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 渭南师范学院 | 2026-01-02 | — | — | CN | disclosed |
| CN-116751157-B | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2025-09-12 | — | — | CN | disclosed |
| CN-116751157-B | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2025-09-12 | — | — | CN | disclosed |
| CN-119798149-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 宜昌天睿生物医药有限责任公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119798149-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 宜昌天睿生物医药有限责任公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-119798149-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 宜昌天睿生物医药有限责任公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-115974835-B | Synthesis method of key intermediate of timonazolam | 湖南复瑞生物医药技术有限责任公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-115974835-B | Synthesis method of key intermediate of timonazolam | 湖南复瑞生物医药技术有限责任公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119192183-A | Benzodiazepines class of compounds and uses thereof | 中国药科大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-119143662-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 广西鲲宇药业有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119143662-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 广西鲲宇药业有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119143662-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 广西鲲宇药业有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119072467-A | Novel diazapine compounds targeting yellow fever virus non-structural 4B (NS 4B) protein and methods of use thereof | 巴鲁克斯布伦博格研究所 | 2024-12-03 | — | — | CN | disclosed |
| WO-2024214109-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM AND SALTS THEREOF | HARMAN FINOCHEM LIMITED (IN) | 2024-10-17 | — | — | WO | disclosed |
| CN-116283968-B | Acetamido imidazopyridine compound and preparation method and application thereof | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2024-08-16 | — | — | CN | disclosed |
| CN-115322144-B | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-115322144-B | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-115322144-B | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-117447467-A | Preparation method of 2-acetyl-1, 10-phenanthroline | 上海再启生物技术有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-117447393-A | Preparation method of intermediate of Rayleigh Malun | 浙江雅辰药物科技股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-115626913-B | Method for preparing key intermediate of Rayleigh Malun | 上海再启生物技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-115626913-B | Method for preparing key intermediate of Rayleigh Malun | 上海再启生物技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116751157-A | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116751157-A | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116751157-A | Amplified preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海再启生物技术有限公司 | 2023-09-15 | — | — | CN | disclosed |
| CN-116283968-A | Acetamido imidazopyridine compound and preparation method and application thereof | 广东省科学院测试分析研究所(中国广州分析测试中心) | 2023-06-23 | — | — | CN | disclosed |
| CN-116102558-A | Novel benzodiazepine compound, preparation method and application thereof | 中国药科大学 | 2023-05-12 | — | — | CN | disclosed |
| CN-116041254-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine serving as intermediate of rimazolam | 天津玖合成城企业管理合伙企业(有限合伙) | 2023-05-02 | — | — | CN | disclosed |
| CN-116041254-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine serving as intermediate of rimazolam | 天津玖合成城企业管理合伙企业(有限合伙) | 2023-05-02 | — | — | CN | disclosed |
| CN-116041254-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine serving as intermediate of rimazolam | 天津玖合成城企业管理合伙企业(有限合伙) | 2023-05-02 | — | — | CN | disclosed |
| CN-114644612-B | Preparation method of benzodiazepine nerve inhibitor intermediate compound | 成都苑东生物制药股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-115974835-A | Synthesis method of key intermediate of remimazolam | 湖南复瑞生物医药技术有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115974835-A | Synthesis method of key intermediate of remimazolam | 湖南复瑞生物医药技术有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| WO-2023037237-A1 | PROCESS FOR THE PREPARATION OF REMIMAZOLAM | WAVELENGTH ENTERPRISES LTD (IL) | 2023-03-16 | — | — | WO | disclosed |
| CN-115626913-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-115626913-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2023-01-20 | — | — | CN | disclosed |
| CN-115322144-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322144-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-115322144-A | Preparation method of 2- (2-amino-5-bromo-benzoyl) pyridine | 上海药坦药物研究开发有限公司 | 2022-11-11 | — | — | CN | disclosed |
| CN-113717176-B | Method for preparing remazolam | 上海再启生物技术有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-113717176-B | Method for preparing remazolam | 上海再启生物技术有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-110418791-B | Injection composition comprising benzodiazepine compound and method for preparing the same | 四川科伦博泰生物医药股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114644612-A | Preparation method of benzodiazepine neuroleptic intermediate compound | 成都苑东生物制药股份有限公司 | 2022-06-21 | — | — | CN | disclosed |
| CN-110746345-B | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 苏州永健生物医药有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-110746345-B | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 苏州永健生物医药有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-110746345-B | Synthesis method of 2- (2-amino-5-bromo-benzoyl) pyridine | 苏州永健生物医药有限公司 | 2022-03-04 | — | — | CN | disclosed |
| CN-114014839-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114014839-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-114014839-A | Method for preparing key intermediate of remimazolam | 上海再启生物技术有限公司 | 2022-02-08 | — | — | CN | disclosed |